TrademarkDir
GET CONTRAVE NOW
LIVE

Serial Number

87301815

Owner

Orexigen Therapeutics, Inc.

Attorney

Andrew N. Spivak

First Use Date

Dec 14, 2016

Filing Date

Jan 13, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GET CONTRAVE NOW Trademark

Serial Number: 87301815 • Registration: 5586961

GET CONTRAVE NOW is a trademark filed by Orexigen Therapeutics, Inc. on January 13, 2017. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Orexigen Therapeutics, Inc. (50 trademarks)

3344 North Torrey Pines Court, Suite 200
La Jolla, CA 92037

Entity Type: 03

NALPROPION PHARMACEUTICALS LLC (17 trademarks)

10 NORTH PARK PLACE, SUITE 201
MORRISTOWN, NJ 07960

Entity Type: 16

NALPROPION PHARMACEUTICALS, INC. (10 trademarks)

10 NORTH PARK PLACE, SUITE 201
MORRISTOWN, NJ 07960

Entity Type: 03

Trademark Details

Filing Date

January 13, 2017

Registration Date

October 16, 2018

First Use Anywhere

December 14, 2016

First Use in Commerce

December 14, 2016

Published for Opposition

June 20, 2017

Goods & Services

Online pharmaceutical advice, namely, providing online consultation and information for the ordering of pharmaceuticals; Providing information in the field of weight management and the treatment of obesity

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 22, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 22, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 22, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 24, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 16, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 27, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 27, 2021 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 23, 2019 ASGN
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 12, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 11, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 10, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 10, 2018 AITU
USE AMENDMENT FILED
Aug 14, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 14, 2018 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 8, 2018 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2018 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 16, 2018 EXRA
SOU EXTENSION 1 GRANTED
Feb 14, 2018 EX1G
SOU EXTENSION 1 FILED
Feb 14, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 14, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 15, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 20, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jun 20, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 31, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 18, 2017 PREV
ASSIGNED TO LIE
May 9, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 30, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 30, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 30, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 30, 2017 CNEA
ASSIGNED TO EXAMINER
Mar 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2017 NWOS
NEW APPLICATION ENTERED
Jan 17, 2017 NWAP

Related Trademarks

More from this Owner

STRESS EATING

STRESS EATING

ONE SIZE DOES NOT FIT ALL

ONE SIZE DOES NOT FIT ALL

ONE SIZE DOES NOT FIT ALL

ONE SIZE DOES NOT FIT ALL

NALPROPION PHARMACEUTICALS logo

NALPROPION PHARMACEUTICALS

NALPROPION PHARMACEUTICALS logo

NALPROPION PHARMACEUTICALS

NALPROPION PHARMACEUTICALS logo

NALPROPION PHARMACEUTICALS